Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Pfizer (NYSE:PFE) Shares Up 0.3% | news.google.com • |
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever | fool.com • |
Edgestream Partners L.P. Raises Stake in Pfizer Inc. (NYSE:PFE) | news.google.com • |
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income | news.google.com • |
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income | news.google.com • |
ABBV: 3 High-Dividend Pharma Blue Chips That Are on Sale Right Now | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-10-29 | 2024-09 | 0.63 | N/A | N/A | N/A |
2024-07-30 | 2024-06 | 0.45 | 0.6 | 0.15 | 33.33% |
2024-05-01 | 2024-03 | 0.56 | 0.82 | 0.26 | 46.43% |
2024-01-30 | 2023-12 | -0.19 | 0.1 | 0.29 | 152.63% |
2023-10-31 | 2023-09 | -0.32 | -0.17 | 0.15 | 46.88% |
2023-08-01 | 2023-06 | 0.56 | 0.67 | 0.11 | 19.64% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-16 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-10-16 | Morgan Stanley | Upgrade | Equal-Weight | Equal-Weight |
2023-10-16 | Truist Securities | Upgrade | Buy | Buy |
2023-10-15 | Jefferies | Upgrade | Hold | Buy |
2023-10-15 | Wells Fargo | Upgrade | Equal-Weight | Equal-Weight |
2023-10-15 | JP Morgan | Upgrade | Neutral | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-27 | BOSHOFF CHRISTOFFEL | Officer | 156.63K | Stock Award(Grant) |
2024-02-22 | BOURLA ALBERT | Chief Executive Officer | 332.49K | Conversion of Exercise of derivative security |
2024-08-12 | DAMICO JENNIFER B. | Officer | 8.58K | Sale |
2024-02-26 | DE GERMAY ALEXANDRE | Officer | 74.38K | Stock Award(Grant) |
2023-12-14 | GOTTLIEB SCOTT | Director | 9.00K | Purchase |
2024-02-22 | JOHNSON RADY A | Officer | 103.45K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 508.09M | 18.64B | 9.00% |
2023-06-29 | Blackrock Inc. | 445.15M | 16.33B | 7.88% |
2023-06-29 | State Street Corporation | 287.20M | 10.53B | 5.09% |
2023-06-29 | Wellington Management Group, LLP | 233.11M | 8.55B | 4.13% |
2023-06-29 | Capital World Investors | 199.01M | 7.30B | 3.52% |
2023-06-29 | Geode Capital Management, LLC | 112.87M | 4.14B | 2.00% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 176.05M | 6.46B | 3.12% |
2023-06-29 | Vanguard 500 Index Fund | 134.41M | 4.93B | 2.38% |
2023-05-30 | Fidelity 500 Index Fund | 62.81M | 2.39B | 1.11% |
2023-08-30 | SPDR S&P 500 ETF Trust | 62.20M | 2.20B | 1.10% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 58.87M | 2.12B | 1.04% |
2023-08-30 | iShares Core S&P 500 ETF | 52.80M | 1.87B | 0.94% |
Dividend | Date |
---|---|
0.42 | 2024-07-26 |
0.42 | 2024-07-25 |
0.42 | 2024-05-09 |
0.42 | 2024-01-26 |
0.42 | 2024-01-25 |
0.41 | 2023-11-10 |
Split | Date |
---|---|
1054 : 1000 | 2020-11-17 |
3 : 1 | 1999-07-01 |
2 : 1 | 1997-07-01 |
2 : 1 | 1995-07-03 |
2 : 1 | 1991-04-01 |
2 : 1 | 1983-07-01 |
-
$SAVA - A second opinion
*
If you have been following Cassava and their Alzheimers drug PTI-125, you will know that 1 of 2 trial endpoints was not recently met, sending the stock down almost 80%. But, I think the exodus was premature. Here is why:Per the companys press release, one endpoint WAS MET:
A secondary endpoint of CSF levels of IL1-beta, a core biomarker of neuroinflammation from baseline to day 28, was met, Cassava said. The drug was also found to be safe and well-tolerated.Per NIH, neuro inflammation is the CORE issue with
Alzheimers:
Inflammation in Alzheimer's disease (AD) has emerged as a central pathology that likely plays a role in onset and progression of the disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214864/Cycling back to Cassavas press release, they state:
CSF levels of IL1-beta, a core biomarker of neuroinflammation ... was met
To reiterate the NIH definition, Neuro Inflammation is core to the onset and progression of Alzheimers. At some point, Cassava IS going to cycle back around to the secondary endpoint (neuro inflammation), and realize that ALONE constitutes an ALZHEIMER DRUG THAT WORKS.
In this case, traders were SO tuned into the word miss that they MISSED something EXTREMELY IMPORTANT. That the efficacy of PTI-125 towards Neuro Inflammation, in Alzheimers (ALONE), makes it A BLOCKBUSTER DRUG!
-
If you are in a pinch for money or know someone who is Robinhood is giving away a free share. If you know someone who is just getting started in the market its a great way to show them how to buy and sell with limits and stops with nothing invested. No monthly fees, and no commission fees.
-
Great news on Fox about unprecedented speed to Covid 19 vaccine by Fall being done by PFE for high risk and health care workers etc. Let’s hope it is approved-this is a game changer.
-
This shouldn’t be dropping at all they beat earnings and they have a good candidate for a vaccine why is this falling I say buy it
-
This is a STEAL
-
I thought the company buy its shares, but they buy its puts. Fuck!
-
How about if the House do not wanna pay you! It is the game but the House always win. Fuck it!
Thanks -
New 52w high this weekend. Can’t complain.
-
¯ beat tomorrow. Demand of medicines and healthcare is massive this whole year. Can not lose!
-
-
Pfizer (NYSE:PFE) Shares Up 0.3%
news.google.com • -
Edgestream Partners L.P. Raises Stake in Pfizer Inc. (NYSE:PFE)
news.google.com • -
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income
news.google.com • -
Pfizer Inc. (PFE): Among the Best Stocks to Buy for Passive Income
news.google.com • -
ABBV: 3 High-Dividend Pharma Blue Chips That Are on Sale Right Now
news.google.com • -
PFIZER INC : Jefferies gives a Buy rating
news.google.com • -
INTC, MSFT, META, PFE, TSLA: Top Trending Stocks Today- Benzinga
news.google.com • -
Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
news.google.com • -
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
news.google.com • -
Learn to Evaluate (PFE) using the Charts
news.google.com • -
5 Things to Know Before the Stock Market Opens
news.google.com • -
US stocks muted ahead of Fed meeting; Pfizer, Intel gain
news.google.com • -
PFE: 3 Healthcare Stocks With High Analyst Price Targets
news.google.com • -
Pfizer Inc. (PFE): A Bull Case Theory
news.google.com • -
Pfizer Stock Vs. AbbVie
news.google.com • -
Is Pfizer Inc. (PFE) The Most Buzzing Stock To Buy Now?
news.google.com •